Clinical Trials on TCD in France

Total 35 results

Clinique Pasteur
Central Hospital, Nancy, France; University Hospital, Bordeaux; University Hospital... and other collaborators

Completed

Primary Prevention ICD French Registry (DAI-PP)

Evaluation of Primary Prevention ICD in Real Life

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Impact of Attention on Obsessive Thoughts Through THOUGHT (THOUGHTS)

Obsessive Compulsive Disorder OCD

France
Centre Hospitalier Henri Laborit

Recruiting

Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder (3TOC)

OCD

France
University Hospital, Montpellier

Completed

Deep Electrical Neuromodulation in Obsessive-compulsive Disorder (NEP-TOC)

Obsessive-compulsive Disorder (OCD)

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Active, not recruiting

Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (CREDO2)

CD

Belgium, France
Abbott Medical Devices
Thoratec Europe Ltd

Completed

Screening for Advanced Heart Failure Treatment (SEE-HF) (SEE-HF)

Advanced Heart Failure | CRT and/or ICD

Netherlands, Sweden, Denmark, France, Germany, United Kingdom
Biotronik, Inc.

Completed

TRUST: Lumos-T Safely RedUceS RouTine Office Device Follow-up (TRUST)

Patient Indicated for an ICD

United States, Canada
University Hospital, Montpellier

Completed

Polyphenols and Insulin Resistance (POLYOXRESIST)

Insulin Resistance | Healthy Volunteers | Type 2 Diabetes (T2D)

France
MicroPort CRM

Unknown

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector (FRIENDS)

Heart Failure | Ventricular Arrythmia | ICD | Lead

Spain, Italy, France, Portugal
Nantes University Hospital
University Hospital, Angers

Recruiting

Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 With Non-alcoholic Hepatic Steatosis (STEATO-POMPE)

Type 2 Diabetes (T2D)

France
Groupe d'Etude Therapeutique des Affections Inflammatoires...
AbbVie; Gilead Sciences; Roche Pharma AG; Takeda; Celgene; Biogen

Completed

Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)

CD

Belgium, France
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess (MICA)

CD

France
Hospital de Clinicas de Porto Alegre

Unknown

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

Quality of Life | OCD

Brazil
Argo Sante
Filière de santé maladies rares MCGRE; Fédération des malades drépanocytaires... and other collaborators

Completed

Evaluation of Impact of Disease on Quality of Life, Education and Socio-professional Integration of Adults and Parents of Children Living With Sickle- Cell Disease in France (DREPAtient)

Sickle-cell Disease (SCD)

France
MicroPort CRM

Active, not recruiting

Observational Study on Inappropriate Therapies (OSIRIS)

Inappropriate Shocks From Implanted Defibrillator | ICD Replacement or Upgrade

Netherlands, United States, France, Spain, Belgium, Switzerland, Italy, United Kingdom, Germany, Austria, Portugal
Institut National de la Santé Et de la Recherche...

Recruiting

Objective Characterizatoion of Repetitive Behaviors

OCD | Tic Disorders | Gilles de la Tourette Syndrome

France
University Hospital, Grenoble
French National Society of Gastroenterology; Association François Aupetit

Completed

Cognition and Emotion in the SII and IBD (EMOTION)

Irritable Bowel Syndrome | Ulcerative Colitis | Inflammatory Bowel Disease (IBD) | Crohn's Disease(CD)

France
French Innovative Leukemia Organisation
Acute Leukemia French Association

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia (OGILAR)

AML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
Nantes University Hospital

Completed

Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients (S-ICD Brugada)

Brugada Syndrome | S-ICD System (Implantable Defibrillator)

Spain, France, Denmark, Germany, Italy
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Active, not recruiting

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab (CURE)

CD

France, Belgium
French Innovative Leukemia Organisation
Acute Leukemia French Association

Completed

A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE (ELEGANCE)

Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITD

France
Alexion

Active, not recruiting

Safety, Efficacy, Pharmacokinetic, and Pharmacodynamic Study of ALXN1820 in Adult Participants With Sickle Cell Disease (PHOENIX)

Sickle Cell Disease (SCD)

United States, France
Aerocrine AB

Completed

NIOX VERO Nasal Application in Primary Ciliary Dyskinesia

PCD

France, United States, Denmark, Germany
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

Sickle Cell Disease (SCD)

United States
Amgen

Completed

Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Type II Refractory Celiac Disease

Type II Refractory Celiac Disease (RCD-II) | In-situ Small Bowel T-cell Lymphoma

Spain, United States, Finland, France, Netherlands
Eli Lilly and Company

Active, not recruiting

A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1) (QWINT-1)

Type 2 Diabetes | T2D

United States, Mexico, Argentina, Puerto Rico
Eli Lilly and Company

Active, not recruiting

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2D

United States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
AbbVie

Active, not recruiting

A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease

Crohn's Disease (CD)

United States, Belgium, Canada, Czechia, Denmark, France, Germany, Hungary, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Romania, Slovakia, Spain, United Kingdom
Biotronik SE & Co. KG

Completed

Ability of Home Monitoring® to Detect and Manage the Inappropriate Diagnoses in Implantable Cardioverter Defibrillators. (THORN)

Atrial Fibrillation | Ventricular Fibrillation | Ventricular Tachycardia | Sudden Cardiac Death | ICD

France
Novartis Pharmaceuticals

Active, not recruiting

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (STAND)

Sickle Cell Disease (SCD)

United States, United Kingdom, Germany, Spain, Greece, Italy, Brazil, Lebanon, Turkey, Belgium, France, Jordan, India, Finland, Canada, Colombia, Netherlands, Oman, South Africa, Panama, Ghana
Novartis Pharmaceuticals

No longer available

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy (AMLFLT3)

Acute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)

United States
AbbVie

Active, not recruiting

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) (SEQUENCE)

Crohn's Disease (CD)

United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Slo... and more
Novartis Pharmaceuticals

Recruiting

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Sickle Cell Disease (SCD)

United States, Germany, Spain, Belgium, Italy, Lebanon, Brazil, Colombia, Oman, Switzerland, Turkey, United Kingdom, Canada, India, France
Novartis Pharmaceuticals

Completed

Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease (STEADFAST)

Sickle Cell Disease (SCD)

United Kingdom, Spain, Greece, Brazil, Turkey, United States, France, Netherlands, Lebanon, Panama, Ireland
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Autoimmune Diseases | Hodgkin Lymphoma | Hematologic Malignancies | Acute Lymphoblastic Leukemia (ALL) | Non-hodgkin Lymphoma | Severe Aplastic Anemia | Inherited Disorders of Metabolism | Inherited Abnormalities of Platelets | Histiocytic Disorders | Acute Myelogenous Leukemia (AML or ANLL) | Other Acute... and other conditions

United States

Clinical Trials on TCD in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations